Lupin informs about press release

09 Aug 2017 Evaluate

Lupin has informed about a press release titled ‘ Lupin receives FDA approval for NikitaTM (Pitavastatin) Tablets’.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2127.25 -23.80 (-1.11%)
01-Feb-2026 14:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1613.00
Dr. Reddys Lab 1198.55
Cipla 1325.10
Zydus Lifesciences 887.00
Lupin 2127.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×